Skip to main content
. 2020 Dec 9;2020:1285216. doi: 10.1155/2020/1285216

Table 1.

Characteristics of participants according to osteopenia status.

Parameters Control Osteopenia p values
N 216 223
Anthropometrics
 Age (years) 53.5 ± 6.0 55.8 ± 8.0 0.001
 Age of menopause (years) 4.0 (2.0-7.0) 6.0 (3.0-10.0) <0.001
 BMI (kg/m2) 34.1 ± 5.4 33.5 ± 5.7 0.26
 WHR 0.9 ± 0.1 0.9 ± 0.1 0.99
 Systolic BP (mmHg) 124.8 ± 17.8 130.0 ± 18.3 0.004
 Diastolic BP (mmHg) 75.3 ± 11.1 76.8 ± 12.2 0.19
 Glucose (mmol/l) 7.8 ± 3.2 7.7 ± 3.2 0.68
 Insulin (ng/ml) 0.47 (0.31-0.68) 0.55 (0.32-0.98) 0.44
Lipids
 Total cholesterol (mmol/l) 4.9 ± 0.9 5.0 ± 1.0 0.15
 Triglycerides (mmol/l) 1.6 (1.2-2.3) 1.6 (1.2-2.3) 0.77
 HDL-cholesterol (mmol/l) 1.1 ± 0.3 1.1 ± 0.3 0.72
Bone turnover markers
T-score (AP spine) -0.3 (-0.7-0.3) -1.7 (-2.1--1.2) <0.001
T-score (dual femur left) 0.7 (0.0-1.3) -0.5 (-1.1-0.3) <0.001
 25(OH)D (nmol/l) 60.6 (35.4-82.7) 61.3 (38.8-89.2) 0.70
 VDBP (μg/ml) 11.0 (5.9-46.6) 14.9 (4.7-54.5) 0.76
 PTH (pg/ml) 11.0 (6.6-19.1) 15.4 (9.6-27.5) 0.004
 DKK1 (ng/ml) 3.1 (1.98-4.1) 3.1 (2.1-3.8) 0.88
 OPG (ng/ml) 0.72 (0.50-0.95) 0.78 (0.58-1.07) 0.14
 OPN (ng/ml) 2.3 (1.3-3.4) 2.5 (1.4-3.4) 0.78
 RANKL (pg/ml) 34.3 (20.6-66.3) 24.0 (18.5-39.4) 0.001
 SOST (ng/ml) 1.4 (0.61-2.7) 1.6 (0.8-2.3) 0.95
 Osteocalcin (ng/ml) 8.8 (2.9-13.1) 8.7 (3.4-14.0) 0.71
 ß-Crosslap (ng/ml) 0.1 (0.0-0.1) 0.1 (0.0-0.1) 0.11
 Total pyridinoline (ng/ml) 15.1 (7.0-31.3) 15.5 (7.5-29.4) 0.90
 NTx (nmol/l) 49.1 (37.0-64.7) 55.9 (40.9-84.7) 0.06
Interleukins
 IL6 (pg/ml) 7.5 (3.2-25.5) 12.1 (6.4-25.6) 0.013
 IL1B (pg/ml) 1.6 (0.4-2.7) 2.0 (0.3-2.7) 0.39
 IL4 (pg/ml) 7.7 (4.7-10.4) 6.5 (3.2-10.0) 0.15
Adipocytokines
 Leptin (ng/ml) 16.9 (8.1-33.2) 19.7 (8.4-37.0) 0.38
 TNF-α (pg/ml) 1.6 (1.1-2.3) 1.9 (1.4-2.6) 0.032
Growth factors
 FGF23 (pg/ml) 62.6 ± 24.2 65.3 ± 23.2 0.30
 TGF β (ng/ml) 41.2 (35.1-52.8) 38.4 (25.7-47.6) 0.06
 IGF-1 (ng/ml) 17.8 (12.1-43.0) 12.8 (11.4-18.5) 0.29